Miguel Blanca,Paul Whitaker
Miguel Blanca
The allergic eye: recommendations about pharmacotherapy and recent therapeutic agents [0.03%]
过敏性眼病的药理治疗建议及最近的治疗方法
Nofar Kimchi,Leonard Bielory
Nofar Kimchi
Purpose of review: Ocular allergies affect an estimated 40% of the population, 98% of which are because of allergic conjunctivitis. With the current advent of both repurposed drugs for ocular allergies, as well as novel d...
The show must go on: an update on clinical experiences and clinical studies on novel pharmaceutical developments for the treatment of atopic dermatitis [0.03%]
行远必自迩 纳新不弃旧——特应性皮炎新型药物临床经验和研究进展更新
Tatjana Honstein,Thomas Werfel
Tatjana Honstein
Purpose of review: This review reports on published clinical studies (full publications) with novel therapeutic agents on the treatment of atopic dermatitis with a focus on the last 2 years. ...
T Joseph Mattingly nd
T Joseph Mattingly nd
Purpose of review: As drug allergy research aims to inform clinical practice, implementation of best practices may be influenced by financial resources required to incorporate new interventions and the resulting clinical ...
Javier Fernandez,María Ruano-Zaragoza,Natalia Blanca-Lopez
Javier Fernandez
Purpose of review: Omalizumab has been proposed for controlling adverse reactions during drug desensitization. Our aim is to know the current evidence involving the use of omalizumab in drug-allergy desensitization. ...
Ashley L Devonshire,Sandy Durrani,Amal Assa&#x;ad
Ashley L Devonshire
Purpose of review: Is to highlight the recent advances in the diagnosis and management of non-IgE-mediated food allergy which is a common consideration in primary care and in allergy and gastroenterology subspecialty prac...
Alessandro Fiocchi,Motohiro Ebisawa
Alessandro Fiocchi
Alessandro Fiocchi,Motohiro Ebisawa
Alessandro Fiocchi
Precision medicine in clinical oncology: the journey from IgG antibody to IgE [0.03%]
临床肿瘤精准医疗的历程：从IgG抗体到IgE
Judit Fazekas-Singer,Josef Singer,Erika Jensen-Jarolim
Judit Fazekas-Singer
Purpose of review: Cancer is one of the leading causes of death and the incidence rates are constantly rising. The heterogeneity of tumors poses a big challenge for the treatment of the disease and natural antibodies addi...